iShares U.S. Pharmaceuticals ETF (IHE)
ETF analysis · AMEX · Financial Services · Asset Management
$103.35
Market Cap
$1.17B
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.48
Day Range
$102.28 – $103.63
52-wk Range
$73.76 – $108.66
Avg Volume
N/A
Volume
249.87K
iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund in the Financial Services sector. Latest price: $103.35. Market cap $1.17B. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 5 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signup1-Year Price
Proprietary Signals
About iShares U.S. Pharmaceuticals ETF
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Peers
Recent News
- Capital Investment Advisors LLC Makes New $630,000 Investment in iShares U.S. Pharmaceuticals ETF $IHE
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- From Laggard to Leader: The Surprising Comeback of Healthcare
- Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?
- Better Pharma ETF: iShares IHE vs. State Street XPH
Related
Browse more tickers: sitemap